Desoxyn
Compare with other ADHD Medications
Compare
| Desoxyn |
VS |
ADHD Medications |
|
|
Basic Information |
| Generic Name |
|
Methamphetamine |
4.8% ADHD Medications have methamphetamine |
| Class |
|
Anorexiants, Cns Stimulants |
4.8% ADHD Medications have anorexiants CNS stimulants |
| Prescription Generic Available |
|
Yes |
61.9% ADHD Medications have Prescription Generic Available
|
| Pregnancy cat. |
|
C(US) |
85.7% ADHD Medications have C(US) |
| Approved Age |
|
6 And Older |
85.7% ADHD Medications have 6 and older
|
| Legal Status |
|
Schedule Ii (us) |
|
| Dependence Liability |
|
High |
76.5% ADHD Medications have High
|
| Excretion |
|
Renal |
15.8% ADHD Medications have Renal |
| Possible Side Effects |
|
Some Loss Of Appetite, Weight, Dry Mouth, Headache, Sleep Problems, Irritability, Agitation, Anxiety, Addiction |
|
|
|
|
Dosage, Usage and Forms |
| Routes (of administration) |
|
Ingestion, Intravenous, Insufflation, Inhalation, Suppository |
|
| Dosage |
|
5 Mg Q Am–10 Mg Bid |
|
| Maximum daily dose |
|
|
|
| Duration |
|
Short-acting |
28.6% ADHD Medications have Short-acting
|
| Duration - time |
|
3-5 H |
9.5% ADHD Medications have 3-5 h
|
|
|
Chemical Data |
| Molecular mass (g/mol) |
|
149.2337 G/mol |
|
| Half Life |
|
9-12 Hours |
|
| Formula |
|
C10H15N |
|
| Bioavailability |
|
62.7% Oral; 79% Nasal; 90.3% Smoked; 99% Rectally; 100% Iv |
|
| Metabolism |
|
Hepatic |
|